Arcadia Biosciences, Inc. — Director's Dealing 2020

Jul 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2020-07-08

Reporting Person: Murray Lilian Shackelford (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-08	Stock Option (right to buy)	$3.73	A	753	Acquired	2030-07-08	Common Stock (753)	Direct

Footnotes

F1: The Option will become 100% vested and exercisable on July 8, 2021.